Innovation

HighLife Medical Raises More Than $90 Million To Advance U.S. Clinical Study And European Expansion

By Amit Chowdhry ● Sep 22, 2026

HighLife Medical, a Paris-based medical technology company developing transcatheter treatments for structural heart disease, has raised more than $90 million (€80 million) in financing to advance its U.S. clinical development program and accelerate commercial expansion in Europe. The funding round was co-led by Andera Partners, Sofinnova Partners, Supernova Invest, and Mérieux Equity Partners, with participation from new and existing investors.

Anyang Indorama Gases Secures $358 Million From Five Banks To Double Fertilizer Production Capacity In China

By Amit Chowdhry ● Sep 22, 2026

Anyang Indorama Gases, a wholly owned subsidiary of Singapore-based Indorama Corporation, has secured RMB 2.4 billion, approximately $358 million, in long-term financing from a consortium of five banks to fund its Phase II fertilizer expansion project in Anyang City, Henan Province, China. The lenders include OCBC Bank, Bank of China, Bank of Communications, Bangkok Bank (China), and China CITIC Bank. The investment is expected to double the company's annual urea fertilizer production capacity to approximately 2 million metric tons by 2029.

Cyera Raises $400 Million From Goldman Sachs At Over $12 Billion Valuation

By Amit Chowdhry ● Sep 22, 2026

Cyera, an artificial intelligence and data security company, has secured a $400 million investment from Growth Equity at Goldman Sachs Alternatives through an extension of its Series G financing round, which was led by Evolution Equity. The investment will accelerate Cyera's development of a unified data and identity security platform for enterprises deploying autonomous AI agents. The company reports a valuation exceeding $12 billion.

Millrose Properties Launches $1 Billion Senior Notes Offering To Support Dream Finders Transaction And Repay Debt

By Amit Chowdhry ● Sep 22, 2026

Millrose Properties, a Miami-based homesite financing and development platform, has announced plans to offer up to $1 billion in senior notes across two separate tranches. The proposed private offering consists of $500 million in senior notes due 2029 and $500 million in senior notes due 2031. The company intends to use the proceeds, together with $500 million from its delayed draw term loan facility, for general corporate purposes, potential homesite acquisitions, and debt repayment.

Solaris Energy Infrastructure Launches $1 Billion Senior Notes Offering Due 2032

By Amit Chowdhry ● Sep 22, 2026

Solaris Energy Infrastructure has announced plans to offer $1 billion in senior notes due 2032 through its subsidiary, Solaris Energy Infrastructure LLC. The company intends to use the net proceeds for general corporate purposes, growth-related capital expenditures, and expenses associated with the offering. The transaction is subject to market conditions and customary closing requirements.

Beagle Labs Raises $4.1 Million In Pre-Seed Funding Led By Chingona Ventures

By Amit Chowdhry ● Sep 22, 2026

Beagle Labs, an AI-powered property intelligence platform for commercial insurance underwriting, has raised $4.1 million in pre-seed funding led by Chingona Ventures. Additional investors include Sovereign's Capital, Remarkable Ventures, C2 Ventures, South Loop Ventures, and Red Bike Capital. The company will use the funding to expand its technology platform, develop additional AI capabilities, strengthen customer support, and grow its team.

Peakline Partners Acquires Kalon Capital To Expand Equipment Finance Platform

By Amit Chowdhry ● Sep 22, 2026

Peakline Partners has acquired Kalon Capital, a Stamford, Connecticut-based equipment finance company, expanding its capabilities in mid-ticket equipment financing and asset-backed private credit. The acquisition brings Kalon's financing platform and experienced management team into Peakline's investment business, strengthening its ability to originate equipment financing transactions directly and serve businesses across the United States.

meshIQ Launches AgentIQ To Provide Real-Time Governance And Control Over Enterprise AI Agents

By Amit Chowdhry ● Sep 22, 2026

meshIQ has launched AgentIQ, a new AI agent governance solution designed to provide enterprises with real-time visibility, oversight, and control over autonomous AI agents. The platform operates directly within an agent's execution flow, allowing organizations to enforce policies, intervene in potentially risky activities, and maintain comprehensive audit records as AI agents operate across different enterprise systems and frameworks.

Pinterest Unveils Visual Search Ads And New AI-Powered Advertising Tools

By Amit Chowdhry ● Sep 22, 2026

Pinterest has introduced Visual Search Ads, a new advertising format designed to help brands reach consumers as they search visually for products, compare options, and make purchasing decisions. Announced on September 17, 2026, during the company's annual Pinterest Presents advertiser summit, the new offering combines visual search technology with advertising placements across Pinterest Search Results and Pin closeups.

Nscale IPO Filing Reveals $103.4 Billion In Active And Contracted AI Infrastructure Agreements

By Amit Chowdhry ● Sep 22, 2026

Nscale has filed for an initial public offering on the New York Stock Exchange, revealing $103.4 billion in active and contracted total contract value (TCV) as of August 31, 2026. The London-based artificial intelligence infrastructure company disclosed the figure in its September 18 filing with the U.S. Securities and Exchange Commission, highlighting the scale of its agreements with major technology companies and AI developers. Nscale plans to list on the NYSE under the ticker symbol NSCL.

GRAIL Shares Surged As FDA Staff Reviews Galleri Multi-Cancer Blood Test

By Amit Chowdhry ● Sep 22, 2026

GRAIL shares surged 35% after U.S. Food and Drug Administration staff reviewers raised no major concerns regarding key analytical and safety aspects of Galleri, the company’s blood-based multi-cancer screening test. The development comes ahead of a September 23, 2026 meeting of the FDA’s Molecular and Clinical Genetics Panel, which will review GRAIL’s application for premarket approval of Galleri.

Eli Lilly Breaks Ground On $6.5 Billion Houston Manufacturing Facility

By Amit Chowdhry ● Sep 22, 2026

Eli Lilly and Company has broken ground on a $6.5 billion manufacturing facility in Houston, Texas, marking another milestone in the pharmaceutical company's $50 billion initiative to expand domestic medicine production. The facility is one of 10 U.S. manufacturing sites Lilly has announced since 2020 and will produce active pharmaceutical ingredients (APIs) for Foundayo (orforglipron), the company's first synthetic oral GLP-1 medicine, alongside other small-molecule medicines and advanced therapeutics.

Oura Seeks Up To $2.2 Billion At $15.6 Billion IPO Valuation

By Amit Chowdhry ● Sep 22, 2026

Oura and some of its existing shareholders are seeking to raise as much as $2.2 billion through a U.S. initial public offering that could value the smart-ring maker at approximately $15.62 billion, according to Reuters.

Michigan CDFI Coalition Approved For Up To $10 Million Loan From Michigan Strategic Fund

By Amit Chowdhry ● Sep 22, 2026

The Michigan Economic Development Corporation (MEDC) announced that the Michigan Strategic Fund (MSF) Board has approved a loan of up to $10 million to the Michigan CDFI Coalition. The funding will increase lending capital available to Michigan-based, non-depository Community Development Financial Institutions (CDFIs), supporting small businesses, affordable housing, and community development projects throughout the state.

Tricentis: Interview With Chief Product Officer Eran Sher About Agentic Quality Engineering

By Amit Chowdhry ● Sep 22, 2026

Tricentis provides an end-to-end enterprise agentic quality engineering platform designed to help the world’s largest organizations scale software quality at the speed of AI while maintaining governance and human oversight. Its portfolio includes Tosca for test automation, qTest for test management and visibility, NeoLoad for performance testing, SeaLights for quality intelligence, and a growing set of AI agents coordinated through Tricentis AI Workspace. Pulse 2.0 interviewed Tricentis Chief Product Officer Eran Sher to learn more.

Michigan State University Research Foundation Breaks Ground On $20 Million Rosenberg Center

By Amit Chowdhry ● Sep 22, 2026

The Michigan State University Research Foundation (MSU Research Foundation) has officially broken ground on the Rosenberg Center, a $20 million, 65,000-square-foot innovation hub on Michigan State University's campus in East Lansing. I had the opportunity to attend the groundbreaking ceremony, and it was wonderful to see the university, business leaders, and Michigan's entrepreneurial community come together to celebrate this major investment in the region's innovation economy. The facility is expected to open in summer 2027 and will bring startups, researchers, investors, and corporate partners together to accelerate the commercialization of new technologies.

Hunt Scanlon Ventures Invests In Millionways, Building The Behavioral Intelligence Layer For AI

By Amit Chowdhry ● Sep 22, 2026

Hunt Scanlon Ventures, an M&A advisory firm focused on the human capital markets, has completed an investment in millionways, a New York-headquartered frontier lab building a behavioral intelligence layer for AI. millionways pioneered the development of a proprietary Large Psychology Model, Thorsten-4, designed to understand human signals, motives, communication patterns, and behavior, with applications across AI governance, executive hiring, talent management, and leadership assessment.

Nexstrom Raises $12 Million Seed Funding To Commercialize 12-Inch 2D Semiconductor Wafers For AI Chips

By Amit Chowdhry ● Sep 22, 2026

Nexstrom has raised a $12 million seed round to commercialize its wafer-scale 2D semiconductor platform, which is being developed to help chipmakers move beyond the physical limitations of silicon for next-generation AI and high-performance computing systems.

Sela’s AI Agents Help Originate $1 Billion In Loans Per Month, Company Raises $21 Million

By Amit Chowdhry ● Sep 22, 2026

Sela, the market-leading voice AI system for mortgage sales, has announced a total of $21 million in funding across Seed and Series A, led by Costanoa, with participation from Emergence Capital. Sela's AI agents currently help loan officers originate more than $1 billion in new mortgages per month, and the company has crossed $10 million in annualized run-rate revenue in 18 months. Six of the ten largest independent mortgage banks now use Sela.

Ambitious Bio Launches Corpus To Map Protein Presence Across Healthy Human Tissues

By Amit Chowdhry ● Sep 22, 2026

Ambitious Bio, a life sciences and AI infrastructure company building systematic records of human biology for artificial intelligence, announced the launch of Corpus, a comprehensive map of protein presence and relative abundance across healthy human tissues.

AttackIQ Names Former DISA CTO Dave Mihelcic As Federal Field CTO To Lead AI-Powered Cyber Defense Expansion

By Amit Chowdhry ● Sep 22, 2026

AttackIQ has appointed former Defense Information Systems Agency Chief Technology Officer Dave Mihelcic as Field Chief Technology Officer - Federal, adding a veteran government technology leader as the cybersecurity company expands its threat-informed Continuous Threat Exposure Management capabilities across federal agencies.

Cisco Partners With Notre Dame Athletics To Modernize Campus Network For AI Era

By Amit Chowdhry ● Sep 22, 2026

Cisco has entered a multi-year partnership with Notre Dame Athletics to modernize the University of Notre Dame's campus-wide network, deploying advanced networking technologies intended to improve connectivity, resiliency and operational efficiency as artificial intelligence increases demands on higher-education infrastructure.

Blair Health Raises C$4.2 Million Pre-Seed To Close Specialist Gap In Women’s Health

By Amit Chowdhry ● Sep 22, 2026

Blair Health, a clinical infrastructure company that enables generalist healthcare providers to deliver specialist-level care, has raised C$4.24 million in pre-seed financing, marking the company's first institutional round and bringing total capital raised to date to C$4.5 million. The oversubscribed round was co-led by Business Development Bank of Canada's Thrive Venture Fund, Accelia Capital, and Ogaei, with participation from Ontario Centre of Innovation through its Life Sciences Innovation Fund, and angel investors.

H2SITE Secures €3.4 Million In Enova Funding To Scale Onboard Ammonia-To-Power For Maritime

By Amit Chowdhry ● Sep 22, 2026

H2SITE has secured €3.4 million (NOK 39.1 million) in funding from Enova for HydraNord Power, a project that will develop and validate a commercial-scale onboard ammonia-to-power system for the maritime sector. Enova is one of the Norwegian government's primary instruments for accelerating the country's climate and energy transition, managing the Climate and Energy Fund on behalf of the Norwegian government.

Xpansiv And Verdane Announce Strategic Partnership And Capital Raise To Advance Global Acquisitions

By Amit Chowdhry ● Sep 22, 2026

Xpansiv, the infrastructure provider for global energy transition markets, and Verdane, the European growth investment firm, have announced a strategic partnership in which Verdane is leading a major capital raise by Xpansiv. The investment will support Xpansiv's acquisition strategy, continuing the company's expansion into new products, asset classes, and geographies.

EYKON Sells Water Meter Business To Sensus International, Sharpening Strategic Focus

By Amit Chowdhry ● Sep 22, 2026

EYKON and Sensus International, both part of the AURELIUS Midmarket portfolio, have entered into an agreement under which EYKON will sell its water meter business to Sensus International. The agreement enables both organizations to focus on their respective strengths and supports EYKON's strategic focus on the areas where the company has established scale, long-standing customer relationships, and leading positions across its portfolio.

OBE Power Closes Equity Investment From North Sky Capital To Expand EV Charging Network

By Amit Chowdhry ● Sep 22, 2026

OBE Power, an owner and operator of electric vehicle charging infrastructure, has closed an equity investment from North Sky Capital, a pioneer in impact investing in the United States. The investment complements OBE Power's existing credit facility with Gresham House and is intended to support the company's continued growth and the expansion of its fully owned and operated EV charging network across the United States and Canada.

Owl Ventures Welcomes NBA Legend Chris Paul As Venture Partner

By Amit Chowdhry ● Sep 22, 2026

Owl Ventures, the world's largest venture capital firm focused on education and workforce innovation, has announced that NBA legend, entrepreneur, and investor Chris Paul has joined the firm as Venture Partner. Paul served eight years as president of the National Basketball Players Association, representing players through major business, labor, and organizational issues during a transformative period for the league.

Hyperscale Data To Form Patriot BTC To Separate Bitcoin Mining From Michigan AI Data Center Strategy

By Amit Chowdhry ● Sep 22, 2026

Hyperscale Data announced that it is taking steps to form Patriot BTC, a proposed new subsidiary intended to hold the company's cryptocurrency mining operations and related assets as a distinct business. As part of the proposed transaction, Hyperscale Data intends to initially transfer all operating assets used in its cryptocurrency mining operations to Patriot BTC, including the company's Montana data center, Bitcoin miners, mining equipment, and related infrastructure.

MTTI Awarded $3.17 Million NCI Grant To Advance Lu-177-EBRGD For Non-Small Cell Lung Cancer

By Amit Chowdhry ● Sep 22, 2026

Molecular Targeting Technologies, a clinical-stage radiopharmaceutical company, has been awarded a $3.17 million, five-year National Cancer Institute grant to advance the development of Lu-177-EBRGD, an investigational radiopharmaceutical targeting integrin αvβ3, for non-small cell lung cancer. The award, under NIH grant R01CA299133, will support an integrated translational program encompassing preclinical research, drug product manufacturing, regulatory preparation, and planned clinical studies.